>>> CS on pharmaceuticals : Few reco changes...

*MEDA CUT TO NEUTRAL VS OUTPERFORM AT CREDIT SUISSE *GLAXOSMITHKLINE CUT TO UNDERPERFORM AT CREDIT SUISSE *SHIRE PHARMACEUTICALS CUT TO NEUTRAL AT CREDIT SUISSE *IPSEN RAISED TO OUTPERFORM VS UNDERPERFORM AT CREDIT SUISSE